glp-1 injection pen How medications are transforming diabetes and weight loss treatment Injection Pen for GLP-1 Drug

Xu Y, Jiang W, Chen G, Zhu W, Ding W, Ge Z, et al

Pharmacol Res 43(1):2330 Kolgazi M, Ozdemir-Kumral Z, Cantali-Ozturk C, Demirci E, Yuksel M, Sirvanci S et al (2017) Anti-inflammatory effects of nesfatin-1 on acetic acid-induced gastric ulcer in rats: involvement of cyclo-oxygenase pathway

Raj Kannan, CEO of Alveus Therapeutics, which raised $160 million in series A financing in January, says the next generation of drugs is going to be all about the quality and durability of weight lossand that is where amylin analogs hold promise

February 2026: Eli Lilly reported that orforglipron, its once-daily oral GLP-1 receptor agonist, is being evaluated in Phase III studies for weight management in adults with obesity or overweight with at least one weight-related medical condition